CORE
🇺🇦Â
 make metadata, not war
Services
Services overview
Explore all CORE services
Access to raw data
API
Dataset
FastSync
Content discovery
Recommender
Discovery
OAI identifiers
OAI Resolver
Managing content
Dashboard
Bespoke contracts
Consultancy services
Support us
Support us
Membership
Sponsorship
Community governance
Advisory Board
Board of supporters
Research network
About
About us
Our mission
Team
Blog
FAQs
Contact us
Filters
1 research outputs found
Dasatinib vs. imatinib in patients with chronic myeloid leukemia in chronic phase (CML-CP) who have not achieved an optimal response to 3 months of imatinib therapy: the DASCERN randomized study
Author
Cortes Jorge E.
Gurnani Renuka
+12Â more
Hochhaus Andreas
Jiang Qian
Kim Dong-Wook
Liu Xiaoli
Martin-Regueira Patricia
Radich Jerald
Saglio Giuseppe
Savona Michael
Sy Oumar
Wang Jianxiang
Weng Jianyu
Zhu Huanling
Publication venue
Publication date
07/04/2020
Field of study
Get PDF
n/
Open Access Repository